| Serial Number | 79272459 |
| Word Mark | QUIAPEG PHARMACEUTICALS |
| Filing Date | Monday, September 2, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 27, 2022 |
| Registration Number | 6854416 |
| Registration Date | Tuesday, September 27, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 12, 2022 |
| Description of Mark | The mark consists of the wording "QUIAPEG" in blue and "PHARMACEUTICALS" in orange and the design a blue hexagon containing three diagonal blue lines with a wavy orange line emanating from its center. The white in the drawing represents background and is not part of the mark. |
| Goods and Services | Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances |
| Indication of Colors claimed | The color(s) orange and blue is/are claimed as a feature of the mark. |
| Goods and Services | Regents for use in industry and science, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers |
| Translation of Words in Mark | The wording "QUIAPEG" has no meaning in a foreign language. |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Goods and Services | Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 25, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | QuiaPEG Pharmaceuticals AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Party Name | QuiaPEG Pharmaceuticals AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Party Name | QuiaPEG Pharmaceuticals AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | SE |
| Event Date | Event Description |
| Monday, February 6, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, January 18, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, December 27, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, September 27, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, September 27, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 12, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 12, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 12, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 22, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 22, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 22, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, June 3, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 3, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, June 3, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, June 3, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, June 3, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 10, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, April 21, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, April 21, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Tuesday, September 1, 2020 | ATTORNEY REVIEW COMPLETED |
| Tuesday, August 4, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, August 4, 2020 | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
| Friday, July 17, 2020 | LIMITATION OF GOODS RECEIVED FROM IB |
| Tuesday, July 14, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, July 1, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 1, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, July 1, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 1, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 1, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, May 28, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 28, 2020 | ASSIGNED TO LIE |
| Thursday, May 21, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, March 7, 2020 | REFUSAL PROCESSED BY IB |
| Friday, February 14, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, February 14, 2020 | REFUSAL PROCESSED BY MPU |
| Wednesday, January 22, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, January 21, 2020 | NON-FINAL ACTION WRITTEN |
| Thursday, December 5, 2019 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Thursday, December 5, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 4, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 4, 2019 | ASSIGNED TO EXAMINER |
| Friday, November 29, 2019 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 25, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 21, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |